On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released a series of guidance documents addressing the agency's current views on software regulation following the changes implemented in the 21st Century Cures Act (Cures Act) enacted in December 2016.
Please see full publication below for more information.